Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2014 | Short report

Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura

Authors: Kjersti Grøtta Vetvik, E Anne MacGregor, Christofer Lundqvist, Michael Bjørn Russell

Published in: The Journal of Headache and Pain | Issue 1/2014

Abstract

Background

Menstrual migraine without aura (MM) affects approximately 20% of female migraineurs in the general population. The aim of the present study was to investigate the influence of contraception on the attacks of migraine without aura (MO) in women with MM.

Findings

141 women from the general population with a history of MM according to the International Classification of Headache Disorders II (ICHD II) were interviewed by a headache specialist. Of 49 women with a history of MM currently using hormonal contraception, 23 reported amenorrhoea. Significantly more women with amenorrhoea reported no MO- days during the preceding month compared to women without amenorrhoea (OR 16.1; 95% confidence interval (CI) 1.8-140.4; P = 0.003). A reduction of MO-frequency was more often reported in women with than without amenorrhoea (OR 3.5; 95% CI 1.1-11.4; P = 0.04).

Conclusion

Amenorrhoea leads to a reduction of MO-frequency in women with MM using hormonal contraceptives. Future prospective studies on MM should focus on contraceptive methods that achieve amenorrhoea.

Available only for authorised users

Russell MB, Rasmussen BK, Fenger K, Olesen J: Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996, 16(4):239–245. 10.1046/j.1468-2982.1996.1604239.xCrossRefPubMed

Vetvik KG, Macgregor EA, Lundqvist C, Russell MB: Prevalence of menstrual migraine: a population-based study. Cephalalgia 2014, 34(4):280–288. 10.1177/0333102413507637CrossRefPubMed

Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013, 33(9):629–808.CrossRef

Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(1):9–160.

MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A: Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006, 67(12):2154–2158. doi:10.1212/01.wnl.0000233888.18228.19 10.1212/01.wnl.0000233888.18228.19CrossRefPubMed

Machado RB, Pereira AP, Coelho GP, Neri L, Martins L, Luminoso D: Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. Contraception 2010, 81(3):202–208. doi:10.1016/j.contraception.2009.09.006 10.1016/j.contraception.2009.09.006CrossRefPubMed

Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M: Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011, 12(4):443–451. doi:10.1007/s10194–011–0329–1 10.1007/s10194-011-0329-1PubMedCentralCrossRefPubMed

MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A: Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006, 67(12):2159–2163. doi:10.1212/01.wnl.0000249114.52802.55 10.1212/01.wnl.0000249114.52802.55CrossRefPubMed

Sacco S, Ricci S, Degan D, Carolei A: Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 2012, 13(3):177–189. doi:10.1007/s10194–012–0424-y 10.1007/s10194-012-0424-yPubMedCentralCrossRefPubMed

10.

Nattero G, Allais G, De Lorenzo C, Benedetto C, Zonca M, Melzi E, Massobrio M: Relevance of prostaglandins in true menstrual migraine. Headache 1989, 29(4):233–238. 10.1111/j.1526-4610.1989.hed22904233.xCrossRefPubMed

11.

Somerville BW, Carey HM: The use of continuous progestogen contraception in the treatment of migraine. Med J Aust 1970, 1(21):1043–1045.PubMed

12.

Master-Hunter T, Heiman DL: Amenorrhea: evaluation and treatment. Am Fam Physician 2006, 73(8):1374–1382.PubMed

13.

Somerville BW: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22(4):355–365. 10.1212/WNL.22.4.355CrossRefPubMed

14.

Calhoun A, Ford S, Pruitt A: The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache 2012, 52(8):1246–1253. doi:10.1111/j.1526–4610.2012.02211.x 10.1111/j.1526-4610.2012.02211.xCrossRefPubMed

15.

De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A: Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril 2011, 96(4):917–920. doi:10.1016/j.fertnstert.2011.07.1089 10.1016/j.fertnstert.2011.07.1089CrossRefPubMed

16.

MacGregor EA: Contraception and headache. Headache 2013, 53(2):247–276. doi:10.1111/head.12035 10.1111/head.12035CrossRefPubMed

17.

Luukkainen T, Toivonen J: Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995, 52(5):269–276. 10.1016/0010-7824(95)00210-2CrossRefPubMed

18.

Durham PL, Vause CV, Derosier F, McDonald S, Cady R, Martin V: Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache 2010, 50(5):844–851. doi:10.1111/j.1526–4610.2010.01657.x 10.1111/j.1526-4610.2010.01657.xCrossRefPubMed

Title: Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura
Authors: Kjersti Grøtta Vetvik
E Anne MacGregor
Christofer Lundqvist
Michael Bjørn Russell
Publication date: 01-12-2014
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/1129-2377-15-30

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Contraceptive-induced amenorrhoea leads to reduced migraine frequency in women with menstrual migraine without aura

Abstract

Background

Findings

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Findings

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache

Manual therapies for primary chronic headaches: a systematic review of randomized controlled trials

Genetic association and gene expression studies suggest that genetic variants in the SYNE1 and TNF genes are related to menstrual migraine

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation

Gleaning after the European Headache Federation consensus statement on refractory chronic migraine

Migraine among medical students in Kuwait University